Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Mendes

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Plos One|December 29, 2017
Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Plos One|June 21, 2016
Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Plos Pathogens|March 29, 2014
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasSoraya Gaze, Patrick Driguez, Mark S Pearson, et al.
Journal of the American Chemical Society|September 1, 2021
Inverse Conformational Selection in Lipid-Protein BindingAmélie Bacle, Pavel Buslaev, Rebeca Garcia-Fandino, et al.
Acta Neuropathologica|May 9, 2019
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr<sup>348</sup> phosphorylationMaxime Sartori, Tiago Mendes, Shruti Desai, et al.
Molecular Psychiatry|January 5, 2021
Correction to: Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent mannerFanny Eysert, Audrey Coulon, Emmanuelle Boscher, et al.
Molecular Psychiatry|November 4, 2020
Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent mannerFanny Eysert, Audrey Coulon, Emmanuelle Boscher, et al.
Nature Communications|February 7, 2024
Overlay databank unlocks data-driven analyses of biomolecules for allAnne M Kiirikki, Hanne S Antila, Lara S Bort, et al.
Ebiomedicine|June 23, 2016
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Geoffroy Laumet, Anne-Marie Ayral, et al.
Acta Neuropathologica|December 10, 2016
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolismJulien Chapuis, Amandine Flaig, Benjamin Grenier-Boley, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Plos One|December 29, 2017
Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Plos One|June 21, 2016
Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Plos Pathogens|March 29, 2014
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasSoraya Gaze, Patrick Driguez, Mark S Pearson, et al.
Journal of the American Chemical Society|September 1, 2021
Inverse Conformational Selection in Lipid-Protein BindingAmélie Bacle, Pavel Buslaev, Rebeca Garcia-Fandino, et al.
Acta Neuropathologica|May 9, 2019
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr<sup>348</sup> phosphorylationMaxime Sartori, Tiago Mendes, Shruti Desai, et al.
Molecular Psychiatry|January 5, 2021
Correction to: Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent mannerFanny Eysert, Audrey Coulon, Emmanuelle Boscher, et al.
Molecular Psychiatry|November 4, 2020
Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent mannerFanny Eysert, Audrey Coulon, Emmanuelle Boscher, et al.
Nature Communications|February 7, 2024
Overlay databank unlocks data-driven analyses of biomolecules for allAnne M Kiirikki, Hanne S Antila, Lara S Bort, et al.
Ebiomedicine|June 23, 2016
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Geoffroy Laumet, Anne-Marie Ayral, et al.
Acta Neuropathologica|December 10, 2016
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolismJulien Chapuis, Amandine Flaig, Benjamin Grenier-Boley, et al.
Pageof 8